Related Experiment Videos
Problems with 20 or more blood transfusions in 24 hours
The American Surgeon
|July 1, 1987
Summary
Massive transfusions of 20+ blood units in 24 hours are linked to high mortality, especially with shock or pre-existing conditions. Coagulopathy and hypocalcemia are common complications in these critically ill patients.
Area of Science:
- Transfusion Medicine
- Critical Care Medicine
- Hematology
Background:
- Massive transfusions, defined as 20 or more units of blood within 24 hours, are critical interventions for severe hemorrhage.
- The outcomes and complications associated with such massive transfusions require thorough investigation to optimize patient management.
Purpose of the Study:
- To review the outcomes of patients receiving massive transfusions.
- To identify factors associated with mortality in patients undergoing massive transfusions.
Main Methods:
- Retrospective review of 128 patients who received 129 massive transfusions (≥20 units/24h) between August 1980 and August 1985.
- Analysis of mortality rates based on the number of blood units transfused, presence of shock, and pre-existing disease.
- Evaluation of laboratory parameters including platelet counts, prothrombin time (PT), partial thromboplastin time (PTT), and calcium levels.
Main Results:
- Mortality rates increased significantly with the number of blood units transfused and the presence of shock or pre-existing disease, reaching 100% in patients receiving ≥50 units.
- Coagulopathy was clinically diagnosed in 43 patients, but laboratory findings (low platelets, prolonged PT/PTT) did not consistently correlate with plasma product administration.
- Hypocalcemia (total calcium <6.0 mg/dL) and low ionized calcium (<0.70 mmol/L) were prevalent, affecting over 50% of assessed patients.
- Deaths were primarily due to continued bleeding/shock (76%) or severe infections (15%) occurring later.
Conclusions:
- Massive blood transfusions are associated with high mortality, particularly in patients with shock and pre-existing comorbidities.
- Coagulopathy and hypocalcemia are frequent complications that may not correlate well with standard laboratory monitoring or interventions.
- Further research is needed to improve management strategies for patients requiring massive transfusions to reduce mortality and morbidity.